Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Mar 1:4:4.
doi: 10.1186/s40842-018-0054-7. eCollection 2018.

Graves' hyperthyroidism in pregnancy: a clinical review

Caroline T Nguyen  1 , Elizabeth B Sasso  2 , Lorayne Barton  3 , Jorge H Mestman  4
Affiliations
Review

Graves' hyperthyroidism in pregnancy: a clinical review

Caroline T Nguyen et al. Clin Diabetes Endocrinol. .

Abstract

Background: Graves' hyperthyroidism affects 0.2% of pregnant women. Establishing the correct diagnosis and effectively managing Graves' hyperthyroidism in pregnancy remains a challenge for physicians.

Main: The goal of this paper is to review the diagnosis and management of Graves' hyperthyroidism in pregnancy. The paper will discuss preconception counseling, etiologies of hyperthyroidism, thyroid function testing, pregnancy-related complications, maternal management, including thyroid storm, anti-thyroid drugs and the complications for mother and fetus, fetal and neonatal thyroid function, neonatal management, and maternal post-partum management.

Conclusion: Establishing the diagnosis of Graves' hyperthyroidism early, maintaining euthyroidism, and achieving a serum total T4 in the upper limit of normal throughout pregnancy is key to reducing the risk of maternal, fetal, and newborn complications. The key to a successful pregnancy begins with preconception counseling.

Keywords: Antithyroid drugs; Hyperthyroidism; Methimazole; Neonatal hyperthyroidism; Pregnancy; Propylthiouracil; TRAb; Thyroid storm.

PubMed Disclaimer

Conflict of interest statement

N/AN/AThe authors declare that they have no competing interests.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

    1. Cooper DS, Laurberg P. Hyperthyroidism in pregnancy. Lancet Diabetes Endocrinol. 2013;1:238–249. doi: 10.1016/S2213-8587(13)70086-X. - DOI - PubMed
    1. Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, Grobman WA, Laurberg P, Lazarus JH, Mandel SJ, Peeters RP, Sullivan S. 2017 guidelines of the American Thyroid Association for the diagnosis and Management of Thyroid Disease during Pregnancy and the postpartum. Thyroid. 2017;27:315–389. doi: 10.1089/thy.2016.0457. - DOI - PubMed
    1. Zimmerman D. Fetal and neonatal hyperthyroidism. Thyroid. 1999;9:727–733. doi: 10.1089/thy.1999.9.727. - DOI - PubMed
    1. Kautbally S, Alexopoulou O, Daumerie C, Jamar F, Mourad M, Maiter D. Greater efficacy of Total thyroidectomy versus radioiodine therapy on hyperthyroidism and thyroid-stimulating immunoglobulin levels in patients with Graves’ disease previously treated with Antithyroid drugs. Eur Thyroid J. 2012;1:122–128. doi: 10.1159/000339473. - DOI - PMC - PubMed
    1. Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G, Torring O. TSH-receptor autoimmunity in Graves’ disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Eur J Endocrinol. 2008;158:69–75. doi: 10.1530/EJE-07-0450. - DOI - PubMed

LinkOut - more resources